Literature DB >> 572510

Reversibility of human myopathy caused by vitamin E deficiency.

L G Tomasi.   

Abstract

Although a neuromuscular syndrome has been induced experimentally by vitamin E deficiency, a human syndrome has not yet been documented. This report describes a 7-year-old boy with severe malabsorption since birth who presented with progressive external ophthalmoplegia, proximal muscle weakness, peripheral neuropathy, hyporeflexia, and bilateral Babinski signs. Abnormalities on neurologic examination included elevated creatine phosphokinase and aldolase, slowed distal sensory latencies, type II muscle fiber atrophy, and a plasma vitamin E level of 8 microgram per deciliter (normal, 550-1500 microgram per deciliter). Treatment with oral water-solubilized vitamin E (400 IU daily; greater than 50 times the normal daily intake) was begun, with repeat laboratory studies at 3-month intervals. Over a 16-month period, plasma vitamin E content gradually increased to 350 microgram per deciliter, associated with declining sarcoplasmic enzyme activities and clinical improvement.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 572510     DOI: 10.1212/wnl.29.8.1182

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Physiological and therapeutic role of vitamin E in humans: an update.

Authors:  K D Moudgil; B S Narang
Journal:  Indian J Pediatr       Date:  1984 Nov-Dec       Impact factor: 1.967

2.  Arrest of neuropathy and myopathy in abetalipoproteinemia with high-dose vitamin E therapy.

Authors:  R A Hegele; A Angel
Journal:  Can Med Assoc J       Date:  1985-01-01       Impact factor: 8.262

3.  Pathology of chronic vitamin E deficiency in fatal familial intrahepatic cholestasis (Byler disease).

Authors:  K Saito; S Matsumoto; T Yokoyama; M Okaniwa; S Kamoshita
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982-08

4.  Neuropathology of chronic vitamine E deficiency in fatal familial intrahepatic cholestasis.

Authors:  K Saito; T Yokoyama; M Okaniwa; S Kamoshita
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

Review 5.  Etiologic factors and pathologic alterations in selenium-vitamin E deficiency and excess in animals and humans.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Biol Trace Elem Res       Date:  1992 Apr-Jun       Impact factor: 3.738

Review 6.  Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.

Authors:  David G Allen; Nicholas P Whitehead; Stanley C Froehner
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 7.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

8.  Biochemical vitamin E deficiency in chronic pancreatitis.

Authors:  I Kalvaria; D Labadarios; G S Shephard; L Visser; I N Marks
Journal:  Int J Pancreatol       Date:  1986-07

9.  Promotion of plasma membrane repair by vitamin E.

Authors:  Amber C Howard; Anna K McNeil; Paul L McNeil
Journal:  Nat Commun       Date:  2011-12-20       Impact factor: 14.919

Review 10.  Effects of vitamin E on cognitive performance during ageing and in Alzheimer's disease.

Authors:  Giorgio La Fata; Peter Weber; M Hasan Mohajeri
Journal:  Nutrients       Date:  2014-11-28       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.